ArticleThe Journal of clinical investigation2019

DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance.

Katsuhiro Togami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.